Pregnancy in a patient with metastatic functioning midgut neuroendocrine tumor receiving lanreotide after peptide receptor radionuclide therapy. [PDF]
Silva BTD +9 more
europepmc +1 more source
[<sup>177</sup>Lu]Lu-DOTATATE Molecular Radiotherapy During Induction Chemotherapy for First-Line Stage 4 High-Risk Neuroblastoma in South African Children: Protocol for a Phase 1 Randomized Controlled Trial (LuDO-SA Trial). [PDF]
van Heerden J +18 more
europepmc +1 more source
Immunogenic cell death as a mechanism of synergy between sunitinib and <sup>177</sup>Lu-DOTATATE peptide receptor radionuclide therapy in pancreatic neuroendocrine tumors. [PDF]
Essler M +4 more
europepmc +1 more source
Emergency Appendectomy during the Early Phase after <sup>177</sup>Lu-DOTATATE Therapy: A Case Report with Perioperative Radiation Safety after PRRT. [PDF]
Nakagawa K +7 more
europepmc +1 more source
A Case of Long-Term Survival after Multimodal Treatments including Living-Donor Liver Transplantation for a Primary Neuroendocrine Tumor of the Bile Duct. [PDF]
Jo A +10 more
europepmc +1 more source
Efficacy of peptide receptor radionuclide therapy in patients with oligodiscordant gastroenteropancreatic neuroendocrine tumours. [PDF]
Mok C +8 more
europepmc +1 more source
Reply to Dal, Z.; Erkan, M. Comment on "Lai et al. Liver Transplantation for the Cure of Neuroendocrine Liver Metastasis: A Systematic Review with Particular Attention to the Risk Factors of Death and Recurrence. <i>Biomedicines</i> 2024, <i>12</i>, 2419". [PDF]
Lai Q +3 more
europepmc +1 more source
The Use of Adjunct Therapies with Surgery for Gastroenteropancreatic Neuroendocrine Tumors: Indications, Timing, and Outcomes. [PDF]
Cavallo K, Nilubol N.
europepmc +1 more source
Krenning score enhances integrated biomarker models for survival prediction in PRRT-treated GEP-NET: a retrospective cohort study. [PDF]
Dascalescu CA +21 more
europepmc +1 more source
Molecular imaging and radioligand therapies in pheochromocytomas and paragangliomas. [PDF]
Hernandez-Felix JH +11 more
europepmc +1 more source

